SQQQ | TAIL | SQQQ / TAIL | |
Gain YTD | -31.726 | 8.706 | -364% |
Net Assets | 3B | 100M | 3,001% |
Total Expense Ratio | 0.95 | 0.59 | 161% |
Turnover | N/A | 13.00 | - |
Yield | 12.03 | 2.64 | 456% |
Fund Existence | 15 years | 8 years | - |
SQQQ | TAIL | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | N/A |
Stochastic ODDS (%) | 2 days ago88% | 2 days ago90% |
Momentum ODDS (%) | 2 days ago90% | 2 days ago72% |
MACD ODDS (%) | 2 days ago86% | 2 days ago66% |
TrendWeek ODDS (%) | 2 days ago90% | 2 days ago80% |
TrendMonth ODDS (%) | 2 days ago90% | 2 days ago82% |
Advances ODDS (%) | 7 days ago87% | 14 days ago65% |
Declines ODDS (%) | 2 days ago90% | 18 days ago80% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago66% |
Aroon ODDS (%) | 2 days ago90% | 2 days ago80% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSCPX | 63.71 | N/A | N/A |
Fidelity Select Consumer Discret Port | |||
PHLCX | 11.87 | N/A | N/A |
PGIM Jennison Health Sciences C | |||
RYMVX | 72.82 | N/A | N/A |
Rydex S&P MidCap 400 Pure Value A | |||
BROAX | 21.89 | N/A | N/A |
BlackRock Advantage International Inv A | |||
MECVX | 15.27 | -0.04 | -0.26% |
NYLI Epoch Capital Growth Investor Class |